NCT03616145

Brief Summary

Parkinson's disease (PD) is a neurological disorder that puts individuals at high risk for injuries and long-term disabilities as a result of a fall or other trauma. Injuries sustained from falls account for many deaths as well as thousands of hospital admissions and nursing home stays every month. Quality of life and even longevity itself is reduced due to the resulting surgeries, immobility, complications and even cognitive impairments that can follow. The proposed study will explore beneficial impact of a treatment modality (OMM/OMT) that may significantly reduce the morbidity of this condition by comparing 6 weeks of OMT versus 6 weeks light touch intervention versus 6 weeks care as usual to improve gait in individuals with PD. Gait will be measured at mid-treatment, post-treatment and 4-week follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
4.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2024

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

July 4, 2018

Last Update Submit

November 9, 2023

Conditions

Keywords

Osteopathic Manipulative Treatment

Outcome Measures

Primary Outcomes (2)

  • Change in Gait

    Gait analysis will be conducted using the Timed Up and Go while wearing the LEGsys+ system. The Legsys body worn sensor system utilizes state-of-the-art camera-based motion capture allowing measurement of advanced gait parameters including stride duration and length, step length, speed, cadence, sagittal plane knee and hip angles, and superior-inferior and medial-lateral pelvis movement, as well as a fall risk assessment.

    0 weeks, 6 weeks, and 10 weeks

  • Change in Balance

    Balance will be measured via the NeuroCom SMART EquiTest system, which enables enables the isolation and assessment of the sensory and muscular components of balance.

    0 weeks, 6 weeks, and 10 weeks

Secondary Outcomes (4)

  • Change in Cognition

    0 weeks, 6 weeks, and 10 weeks

  • Change in PD-Related Health Status

    0 weeks, 6 weeks, and 10 weeks

  • Change in Depressed Mood

    0 weeks, 6 weeks, and 10 weeks

  • Change in Motor Skills

    0 weeks, 6 weeks, and 10 weeks

Study Arms (3)

Osteopathic Manipulative Treatment (OMT)

EXPERIMENTAL

Participants assigned to the OMT arm will receive 6 weekly sessions. The provider will perform the following 14 osteopathic procedures 1) lateral (and anteroposterior) translation of vertebrae in the thoracic/lumbar spine; 2) active myofascial stretch to the thoracic spine; 3) occipito-atlanto release; 4) translation of cervical spine; 5) muscle energy techniques of the cervical spine; 6) Spencer technique applied to the shoulder bilaterally; 7) supination/pronation of the forearm; 8) circumduction of the wrist; 9) sacroiliac joint gapping; 10) muscle energy technique applied to adductor muscles of lower extremity; 11) psoas muscle energy technique; 12) hamstring muscle energy technique; 13) articulatory technique applied to the ankle; 14) and muscle energy technique applied to the ankle in dorsi and plantar flexion. Further, each subject will receive cranial assessment and treatment emphasizing the venous sinus techniques and compression of the fourth ventricle (CV-4).

Procedure: Osteopathic Manipulative Treatment (OMT)

Light Touch

SHAM COMPARATOR

Participants assigned to the light touch comparator arm will receive 30 minutes of light touch procedures designed to be credible but minimally effective. The procedures for the light touch arm are adapted from the methodology established in the North Texas Chronic Low Back Pain Trial, and have been used successfully by the PI as a comparator arm numerous times in the past (e.g., in the OSTEPAThic Trial). Subjects assigned to receive light touch will be treated in positions similar to subjects receiving OMT. Light touch will target each of the 15+ anatomic regions for approximately 1 ½ to 2 minutes each to appropriately control for time, attention, and physical contact. Light touch hand placement will be over the same areas of the body contacted in the OMT protocol, but involve virtually no motion of a meaningful nature, such a range of motion testing which could have therapeutic effect.

Other: Light Touch

Standard of Care Only

NO INTERVENTION

Subjects will continue their usual care and will visit the UCSD for the 4 assessment sessions only, during their course of study participation.

Interventions

Experimental Condition

Osteopathic Manipulative Treatment (OMT)

Comparator Arm

Light Touch

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years.
  • Ambulatory without use of assistive device.
  • Fluency in written and spoken English.
  • Montreal Cognitive Assessment (MoCA) score \> or = 17.
  • Stages 1 - 4 Parkinson's Disease diagnosis as measured by the Unified Parkinson's disease rating scale.

You may not qualify if:

  • Currently enrolled in another clinical trial.
  • Current taking PD medications co-morbid conditions such as pseudobulbar palsy or amyotrophic lateral sclerosis which may have musculoskeletal effects.
  • Individuals with current fractures, tumors, wounds.
  • Any lifetime Deep Brain Stimulation implant surgery.
  • Recent surgeries, eg., within past 90 days.
  • Patients who have experienced hospitalization due to a fall within the past 12 months.
  • Gait abnormalities other than Parkinson's disease.
  • Received OMT or another forms of manipulative therapy within the past two months.
  • Stage 5 Parkinson's Disease diagnosis per as measured by the Unified Parkinson's disease rating scale.
  • Other co-morbid conditions that in the opinion of the PI would interfere with participation in this study.
  • Diagnosis of psychosis or dementia (MoCA, DRS or other indication in eMR).
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Diego

La Jolla, California, 92093, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blinding. The PI, statistician, recruitment personnel, research assistants conducting the assessment sessions, and data entry/verification clerks will be blind to participant's group assignment until data is unlocked at the end of the study. Only the Project Manager who will develop and oversee the randomization procedure, prepare progress reports, and inform participants of their treatment condition will be unblinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The overall design proposed in this study is a randomized, placebo controlled, single-blind controlled trial. Data will be collected in this developmental study to assess potential differences in gait, balance, and quality of life of patients in the intervention arm (6-week OMT intervention coupled with standard of care (SOC) versus the light touch comparator arm (6-week light touch coupled with SOC) versus the non-intervention control arm (SOC alone).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 4, 2018

First Posted

August 6, 2018

Study Start

July 1, 2018

Primary Completion

October 31, 2019

Study Completion

January 21, 2024

Last Updated

November 13, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations